Patently innovative provides a review of the importance of traditional patent law and emerging linkage regulations for pharmaceutical products on the global stage, with a focus on the linkage regime in Canada. The primary focus is on how innovation in the pharmaceutical sector can be strongly regulated and how government regulation can either stimulate or inhibit development of breakthrough products.
Includes empirical research to relate innovation to drug law
A multidisciplinary approach is taken, including the intersection of IP (intellectual property) law, drug law and innovation
Discusses the impact of government regulation on firm innovation